
The administration is calling the move a "radical departure" - but experts say new vaccines already go through placebo-controlled trials The top US health department plans to require placebo testing for all vaccines in an effort to offer "straightforward" public health information, but experts say such testing could limit availability and raise ethical concerns.
Main Idea: Robert F. Kennedy Jr’s health department plans to require placebo trials for all new vaccines, a move experts say could slow access and raise ethical concerns.
Key Points:
Requiring placebo trials for new or changed vaccines could delay shots, raise costs, and make some companies skip updates.
The plan could give the public clearer safety data if the trials are done well.
Rate how each entity in this article affected the American people.
Central named official behind the planned placebo-testing requirement for new vaccines.
Named FDA official quoted on the agency’s review of updated coronavirus shots.
Vaccine expert quoted providing context on existing safety testing for coronavirus shots.
Former FDA official quoted as a critic of the proposal and its ethical implications.
Paul Offit’s institution, mentioned in connection with his vaccine expertise.
Reporting source that first received the HHS statement cited in the article.
Secondary news outlet cited as the BBC’s U.S. partner in reporting on Makary’s remarks.
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to comment